THE TEAM

Ilana du Toit

Founder

FertilyGo was the brainchild of South African Business Woman, Ilana Du Toit. FertilyGo is founded in her own deeply personal reproductive health and fertility journey. “Through my own experience, I came to realize that there was no one specific service or application that allowed users such as myself or my partner to track our entire fertility journey from monthly cycle to pregnancy and everything in between. FertilyGo is a one stop application where individuals have the power to capture and access their data from puberty through to adulthood – without losing information between fertility stages.”

 Ilana was diagnosed with early menopause in 2012 and has seen many Fertility Doctors and clinics in the UK and South Africa. Whilst going through the Fertility treatment process, Ilana realised that there is so much more that could be done to consolidate and streamline the Fertility process and health data management. Ilana realised that, if she knew at the age of 18 that her ovarian egg reserve was diminishing, she could have taken a more proactive approach to managing her reproductive health and her journey could have looked a lot different today. Ilana’s mission is to educate and raise awareness through FertilyGo and help couples get to their desired family outcome quicker and more efficiently. FertilyGo was born to become the data and intelligence partner for the entire reproductive health cycle, providing responsible data access to patients, doctors and health research facilities around the world, allowing patients to move from re-active, to pro-active in their reproductive health journeys.

George Rudman

Head of Technology

George is an innovative, creative and strategic thinker who has, over the past 24 years, been in numerous directorship roles in the information communication technology (ICT), payments and healthcare sectors. George has extensive experience within private and public companies, including the government sector and has managed national and international business and technology developments and has publically listed some of his own technology firms in the past. 

George has over 20 years of invaluable experience in intellectual property management, business development and commercialisation (licensing) of technology across various sectors of industry on a global stage and occupied a director position at the Licensing Executive Society of South Africa. George is a listed inventor on patents registered within South Africa, Europe and the United Kingdom and has published articles on innovation within the United Nations Public Administration Network.

 

JK du Toit

Head of Strategy

JK is a UK qualified Chartered Management Accountant (CPA equivalent)  with a unique skill set and experience in IT, Finance, PPP Projects, HR and for the last 4 years, disruptive technology and Artificial Intelligence. JK is also the CEO of The Talent Index, an Artificial Intelligence Platform that manages people risk for large insurance companies and banks. He has combined his experience and skillset in finance, human capital and technology into a quantitative solution which drives value and insight for corporate on decisions at C-Level with a particular focus on people risk.

 

JK was tasked to design a data strategy and ecosystem for FertilyGo to operate as a global health data ecosystem, allowing global research universities, leading fertility clinics, medical thought leaders and patients to collaborate in a pro-active manner while solving some of the industry’s toughest challenges through data. JK has designed a framework & engaged with globally leading health research houses in Africa and the USA who are currently taking equity positions in FertilyGo, thus positioning FertilyGo as a global leader in reproductive health research, supported by faculties with a combined 4,000 medical researchers supporting the initiative. Beyond this, a number of leading names in Fertility Health in Africa are signing up to FertilyGo, while opening their anonymised patient data and insights for the last 30 years for medical research.